Katharina Faust
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katharina Faust has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Peter Vajkoczy
Charité - University Medicine Berlin
8 shared publicationsGerd-Helge Schneider
Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany
6 shared publications- Andrea A. Kühn
Department of Neurology, Movement Disorders and Neuromodulation Unit, Charité – Universitätsmedizin Berlin, Berlin, Germany
4 shared publications - Jeroen Godefridus Victor Habets
Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
3 shared publications - Johannes L. Busch
Charité - Universitätsmedizin Berlin, Germany
3 shared publications - Peter Vajkoczy
Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Berlin, Germany
3 shared publications
Latest Publications
- Open Access
- 30 July 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e67446
Machine Learning–Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial
Background: The rising prevalence of dementia necessitates a scalable solution to cognitive assessments. The Autonomous Cognitive Examination (ACoE) is a foundational cognitive test for the phenotyping of cognitive symptoms across the primary cognitive domains. However, while the ACoE has been internally validated, it has not been externally validated in a clinical population, and its ability to render accurate appraisals of cognition is unknown. Further, it is unclear if these phenotypic assessments are useful in clinical tasks such as screening patients with and those without impairments. Objective: The objective of this study is to validate the ability of the ACoE to reliably phenotype cognition and to act as a screening examination relative to standard paper-based tests. Methods: To compare the evaluations of the ACoE to established paper-based tests, 46 patients with neurological disorders were enrolled in a randomized crossover study and received either the ACoE or a standard paper-based cognitive test. Patients received either the Addenbrooke Cognitive Examination-3 (ACE-3; n=35) or the Montreal Cognitive Examination (MoCA; n=11). We evaluated 3 primary metrics of the ACoE’s performance relative to paper-based tests: (1) interrater reliability of overall cognitive scores, (2) interrater reliability of cognitive domain scores, and (3) ability to classify patients similarly to paper-based tests. Results: The ACoE’s overall cognitive assessments were significantly reliable (ICC [intraclass correlation coefficient]=0.89; P<.001). Each cognitive domain’s assessments were also significantly reliable, including attention (ICC=0.74; PFWE<.001), language (ICC=0.89; PFWE<.001), memory (ICC=0.91; PFWE<.001), fluency (ICC=0.74; PFWE<.001), and visuospatial function (ICC=0.78; PFWE<.001). The ACoE was also able to successfully diagnose patients similarly to both paper-based tests (area under the receiver operating characteristic curve=0.96; PFWE<.001). Conclusions: In this study, we evaluated if the ACoE could reliably phenotype cognitive symptoms relative to the assessments of established standard paper-based cognitive assessments. We found that the ACoE reliably phenotypes patient cognition, which can be used to screen patients. In the future, these cognitive phenotypes may be used to diagnose specific etiologies.
- 30 July 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e67446
Open AccessMachine Learning–Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial
Background: The rising prevalence of dementia necessitates a scalable solution to cognitive assessments. The Autonomous Cognitive Examination (ACoE) is a foundational cognitive test for the phenotyping of cognitive symptoms across the primary cognitive domains. However, while the ACoE has been internally validated, it has not been externally validated in a clinical population, and its ability to render accurate appraisals of cognition is unknown. Further, it is unclear if these phenotypic assessments are useful in clinical tasks such as screening patients with and those without impairments. Objective: The objective of this study is to validate the ability of the ACoE to reliably phenotype cognition and to act as a screening examination relative to standard paper-based tests. Methods: To compare the evaluations of the ACoE to established paper-based tests, 46 patients with neurological disorders were enrolled in a randomized crossover study and received either the ACoE or a standard paper-based cognitive test. Patients received either the Addenbrooke Cognitive Examination-3 (ACE-3; n=35) or the Montreal Cognitive Examination (MoCA; n=11). We evaluated 3 primary metrics of the ACoE’s performance relative to paper-based tests: (1) interrater reliability of overall cognitive scores, (2) interrater reliability of cognitive domain scores, and (3) ability to classify patients similarly to paper-based tests. Results: The ACoE’s overall cognitive assessments were significantly reliable (ICC [intraclass correlation coefficient]=0.89; P<.001). Each cognitive domain’s assessments were also significantly reliable, including attention (ICC=0.74; PFWE<.001), language (ICC=0.89; PFWE<.001), memory (ICC=0.91; PFWE<.001), fluency (ICC=0.74; PFWE<.001), and visuospatial function (ICC=0.78; PFWE<.001). The ACoE was also able to successfully diagnose patients similarly to both paper-based tests (area under the receiver operating characteristic curve=0.96; PFWE<.001). Conclusions: In this study, we evaluated if the ACoE could reliably phenotype cognitive symptoms relative to the assessments of established standard paper-based cognitive assessments. We found that the ACoE reliably phenotypes patient cognition, which can be used to screen patients. In the future, these cognitive phenotypes may be used to diagnose specific etiologies.
- Open Access
Differential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease
Subthalamic deep brain stimulation (STN-DBS) provides unprecedented spatiotemporal precision for the treatment of Parkinson’s disease (PD), allowing for direct real-time state-specific adjustments. Inspired by findings from optogenetic stimulation in mice, we hypothesized that STN-DBS effects on movement speed depend on ongoing movement kinematics that patients exhibit during stimulation. To investigate this hypothesis, we implemented a motor state-dependent closed-loop neurostimulation algorithm, adapting DBS burst delivery to ongoing movement speed in 24 PD patients. We found a stronger anti-bradykinetic effect, raising movement speed to the level of healthy controls, when STN-DBS was applied during fast but not slow movements, while only stimulating 5% of overall movement time. To study underlying brain circuits and neurophysiological mechanisms, we investigated the behavioral effects with MRI connectomics and motor cortex electrocorticography. Finally, we demonstrate that machine learning-based brain signal decoding can be used to predict continuous movement speed for fully embedded state-dependent closed-loop algorithms. Our findings provide novel insights into the state-dependency of invasive neuromodulation, which could inspire advanced state-dependent neurostimulation algorithms for brain disorders.
Open AccessDifferential modulation of movement speed with state-dependent deep brain stimulation in Parkinson’s disease
Subthalamic deep brain stimulation (STN-DBS) provides unprecedented spatiotemporal precision for the treatment of Parkinson’s disease (PD), allowing for direct real-time state-specific adjustments. Inspired by findings from optogenetic stimulation in mice, we hypothesized that STN-DBS effects on movement speed depend on ongoing movement kinematics that patients exhibit during stimulation. To investigate this hypothesis, we implemented a motor state-dependent closed-loop neurostimulation algorithm, adapting DBS burst delivery to ongoing movement speed in 24 PD patients. We found a stronger anti-bradykinetic effect, raising movement speed to the level of healthy controls, when STN-DBS was applied during fast but not slow movements, while only stimulating 5% of overall movement time. To study underlying brain circuits and neurophysiological mechanisms, we investigated the behavioral effects with MRI connectomics and motor cortex electrocorticography. Finally, we demonstrate that machine learning-based brain signal decoding can be used to predict continuous movement speed for fully embedded state-dependent closed-loop algorithms. Our findings provide novel insights into the state-dependency of invasive neuromodulation, which could inspire advanced state-dependent neurostimulation algorithms for brain disorders.
- 29 July 2024
- Published by Georg Thieme Verlag KG in AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
- Vol. 59 (07/08) , 438-449
Neurochirurgisches Management bei Schädel-Hirn-Trauma
Bei einem Schädel-Hirn-Trauma (SHT) spielen neurochirurgische Therapieentscheidungen eine zentrale Rolle, um das akute Überleben zu sichern sowie um sekundäre Hirnschädigungen, die einen großen Einfluss auf die weitere Lebensqualität der Patient*innen haben, abzumildern. Dieser Beitrag beschreibt das neurochirurgische Management bei SHT, das auf umsichtigen und entschlossenen klinischen Entscheidungen basiert und schnelle chirurgische Interventionen erfordern kann. The neurosurgical management of traumatic brain injury (TBI) plays a critical role in ensuring acute survival and mitigating secondary brain damage, which significantly impacts patients’ quality of life. TBI is defined as an external force impacting the skull, leading to brain injuries and subsequent functional impairments. It is a leading cause of mortality and morbidity, particularly among young individuals. The initial clinical examination is crucial, with external signs like scalp injuries, hematomas, nasal fluid leakage, skull deformities, and neurological deficits providing important clues to injury patterns. Pupil examination is particularly critical, as mydriasis coupled with reduced consciousness may indicate an acute life-threatening increase in intracranial pressure (ICP), necessitating immediate neurosurgical intervention. TBI assessment often utilizes the Glasgow Coma Scale (GCS), classifying injuries as mild (GCS 13–15), moderate (GCS 9–12), or severe (GCS < 9). Even mild TBI can lead to long-term complications. TBI should be viewed as a disease process rather than a singular event. Primary brain damage results from shearing forces on the parenchyma, manifesting as contusions, hematomas, or diffuse axonal injury. Secondary brain damage is driven by mechanisms such as inflammation and spreading depolarizations. Treatment aims not only to secure immediate survival but also to reduce secondary injuries, with ICP management being crucial. Neurosurgical interventions are guided by cranial pathologies, with options including ICP monitoring, burr hole trepanation, craniotomy. In severe TBI cases with refractory ICP elevation, decompressive craniectomy may be performed as a last resort, significantly reducing mortality but often resulting in high morbidity and vegetative states, necessitating careful consideration of indications. Article published online: 29 July 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 29 July 2024
- Published by Georg Thieme Verlag KG in AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
- Vol. 59 (07/08) , 438-449
Neurochirurgisches Management bei Schädel-Hirn-Trauma
Bei einem Schädel-Hirn-Trauma (SHT) spielen neurochirurgische Therapieentscheidungen eine zentrale Rolle, um das akute Überleben zu sichern sowie um sekundäre Hirnschädigungen, die einen großen Einfluss auf die weitere Lebensqualität der Patient*innen haben, abzumildern. Dieser Beitrag beschreibt das neurochirurgische Management bei SHT, das auf umsichtigen und entschlossenen klinischen Entscheidungen basiert und schnelle chirurgische Interventionen erfordern kann. The neurosurgical management of traumatic brain injury (TBI) plays a critical role in ensuring acute survival and mitigating secondary brain damage, which significantly impacts patients’ quality of life. TBI is defined as an external force impacting the skull, leading to brain injuries and subsequent functional impairments. It is a leading cause of mortality and morbidity, particularly among young individuals. The initial clinical examination is crucial, with external signs like scalp injuries, hematomas, nasal fluid leakage, skull deformities, and neurological deficits providing important clues to injury patterns. Pupil examination is particularly critical, as mydriasis coupled with reduced consciousness may indicate an acute life-threatening increase in intracranial pressure (ICP), necessitating immediate neurosurgical intervention. TBI assessment often utilizes the Glasgow Coma Scale (GCS), classifying injuries as mild (GCS 13–15), moderate (GCS 9–12), or severe (GCS < 9). Even mild TBI can lead to long-term complications. TBI should be viewed as a disease process rather than a singular event. Primary brain damage results from shearing forces on the parenchyma, manifesting as contusions, hematomas, or diffuse axonal injury. Secondary brain damage is driven by mechanisms such as inflammation and spreading depolarizations. Treatment aims not only to secure immediate survival but also to reduce secondary injuries, with ICP management being crucial. Neurosurgical interventions are guided by cranial pathologies, with options including ICP monitoring, burr hole trepanation, craniotomy. In severe TBI cases with refractory ICP elevation, decompressive craniectomy may be performed as a last resort, significantly reducing mortality but often resulting in high morbidity and vegetative states, necessitating careful consideration of indications. Article published online: 29 July 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
DBS-induced gamma entrainment as a new biomarker for motor improvement with neuromodulation
Finely tuned gamma oscillations have been recorded from the subthalamic nucleus and cortex in Parkinson’s disease patients undergoing deep brain stimulation and are often associated with dyskinesia. More recently, it was shown that deep brain stimulation entrains finely tuned gamma to ½ of the stimulation frequency; however, the functional role of this signal is not yet fully understood. We recorded local field potentials from the subthalamic nucleus in 19 chronically implanted Parkinson’s disease patients under effective dopaminergic medication and during deep brain stimulation with increasing stimulation amplitude, while they were at rest and during repetitive hand movements. We analyzed the effect of stimulation intensity on gamma band 1:2 entrainment and compared the entrained signal during rest and during repetitive movement. Spontaneous finely tuned gamma was present in eight out of 19 patients (peak frequency μ = 78.4 ±4.3 Hz). High-frequency deep brain stimulation induced 1:2 gamma entrainment in 15 out of 19 patients. Entrainment occurred at a mean stimulation amplitude of 2.2 0.75 mA and disappeared or decreased in power during higher stimulation amplitude in three patients. In patients with spontaneous finely tuned gamma, increasing the stimulation amplitude induced a progressive frequency shift of spontaneous finely tuned gamma until it locked to 1:2 entrainment. Only five out of 15 patients with entrained gamma activity showed dyskinesia during stimulation. Further, there was a significant increase in the power of 1:2 entrained gamma activity during movement in comparison to rest. Finally, patients with entrained gamma activity had faster movements as compared to those without gamma entrainment. These findings argue for a functional relevance of the stimulation-induced 1:2 gamma entrainment in Parkinson’s disease patients as a prokinetic activity that, however, is not necessarily promoting dyskinesia. Previously published electrophysiological models of entrainment fit well to our results and support our findings that stimulation-induced entrainment can be a promising real-life biomarker for closed-loop deep brain stimulation.
Open AccessDBS-induced gamma entrainment as a new biomarker for motor improvement with neuromodulation
Finely tuned gamma oscillations have been recorded from the subthalamic nucleus and cortex in Parkinson’s disease patients undergoing deep brain stimulation and are often associated with dyskinesia. More recently, it was shown that deep brain stimulation entrains finely tuned gamma to ½ of the stimulation frequency; however, the functional role of this signal is not yet fully understood. We recorded local field potentials from the subthalamic nucleus in 19 chronically implanted Parkinson’s disease patients under effective dopaminergic medication and during deep brain stimulation with increasing stimulation amplitude, while they were at rest and during repetitive hand movements. We analyzed the effect of stimulation intensity on gamma band 1:2 entrainment and compared the entrained signal during rest and during repetitive movement. Spontaneous finely tuned gamma was present in eight out of 19 patients (peak frequency μ = 78.4 ±4.3 Hz). High-frequency deep brain stimulation induced 1:2 gamma entrainment in 15 out of 19 patients. Entrainment occurred at a mean stimulation amplitude of 2.2 0.75 mA and disappeared or decreased in power during higher stimulation amplitude in three patients. In patients with spontaneous finely tuned gamma, increasing the stimulation amplitude induced a progressive frequency shift of spontaneous finely tuned gamma until it locked to 1:2 entrainment. Only five out of 15 patients with entrained gamma activity showed dyskinesia during stimulation. Further, there was a significant increase in the power of 1:2 entrained gamma activity during movement in comparison to rest. Finally, patients with entrained gamma activity had faster movements as compared to those without gamma entrainment. These findings argue for a functional relevance of the stimulation-induced 1:2 gamma entrainment in Parkinson’s disease patients as a prokinetic activity that, however, is not necessarily promoting dyskinesia. Previously published electrophysiological models of entrainment fit well to our results and support our findings that stimulation-induced entrainment can be a promising real-life biomarker for closed-loop deep brain stimulation.
- 19 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6693) , 338-343
Directed and acyclic synaptic connectivity in the human layer 2-3 cortical microcircuit
The computational capabilities of neuronal networks are fundamentally constrained by their specific connectivity. Previous studies of cortical connectivity have mostly been carried out in rodents; whether the principles established therein also apply to the evolutionarily expanded human cortex is unclear. We studied network properties within the human temporal cortex using samples obtained from brain surgery. We analyzed multineuron patch-clamp recordings in layer 2-3 pyramidal neurons and identified substantial differences compared with rodents. Reciprocity showed random distribution, synaptic strength was independent from connection probability, and connectivity of the supragranular temporal cortex followed a directed and mostly acyclic graph topology. Application of these principles in neuronal models increased dimensionality of network dynamics, suggesting a critical role for cortical computation.
- 19 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6693) , 338-343
Directed and acyclic synaptic connectivity in the human layer 2-3 cortical microcircuit
The computational capabilities of neuronal networks are fundamentally constrained by their specific connectivity. Previous studies of cortical connectivity have mostly been carried out in rodents; whether the principles established therein also apply to the evolutionarily expanded human cortex is unclear. We studied network properties within the human temporal cortex using samples obtained from brain surgery. We analyzed multineuron patch-clamp recordings in layer 2-3 pyramidal neurons and identified substantial differences compared with rodents. Reciprocity showed random distribution, synaptic strength was independent from connection probability, and connectivity of the supragranular temporal cortex followed a directed and mostly acyclic graph topology. Application of these principles in neuronal models increased dimensionality of network dynamics, suggesting a critical role for cortical computation.
- Open Access
- 22 January 2024
- Published by Elsevier in Brain Stimulation
- Vol. 17 (1) , 125-133
Single threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity
- 22 January 2024
- Published by Elsevier in Brain Stimulation
- Vol. 17 (1) , 125-133
Open AccessSingle threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity
- Open Access
- 18 January 2023
- Published by Wiley in Journal of Neuropsychology
- Vol. 17 (2) , 400-416
Lesion‐symptom mapping of language impairments in people with brain tumours: The influence of linguistic stimuli
People with tumours in specific brain sites might face difficulties in tasks with different linguistic material. Previous lesion‐symptom mapping studies (VLSM) demonstrated that people with tumours in posterior temporal regions have more severe linguistic impairments. However, to the best of our knowledge, preoperative performance and lesion location on tasks with different linguistic stimuli have not been examined. In the present study, we performed VLSM on 52 people with left gliomas to examine whether tumour distribution differs depending on the tasks of the Aachen Aphasia Test. The VLSM analysis revealed that single‐word production ( e.g. object naming) was associated with the inferior parietal lobe and that compound and sentence production were additionally associated with posterior temporal gyri. Word repetition was affected in people with tumours in inferior parietal areas, whereas sentence repetition was the only task to be associated with frontal regions. Subcortically, word and sentence production were found to be affected in people with tumours reaching the arcuate fasciculus, and compound production was primarily associated with tumours affecting the inferior longitudinal and inferior fronto‐occipital fasciculus. Our work shows that tasks with linguistic stimuli other than single‐word naming ( e.g. compound and sentence production) relate to additional cortical and subcortical brain areas. At a clinical level, we show that tasks that target the same processes ( e.g. repetition) can have different neural correlates depending on the linguistic stimuli used. Also, we highlight the importance of left temporoparietal areas.
- 18 January 2023
- Published by Wiley in Journal of Neuropsychology
- Vol. 17 (2) , 400-416
Open AccessLesion‐symptom mapping of language impairments in people with brain tumours: The influence of linguistic stimuli
People with tumours in specific brain sites might face difficulties in tasks with different linguistic material. Previous lesion‐symptom mapping studies (VLSM) demonstrated that people with tumours in posterior temporal regions have more severe linguistic impairments. However, to the best of our knowledge, preoperative performance and lesion location on tasks with different linguistic stimuli have not been examined. In the present study, we performed VLSM on 52 people with left gliomas to examine whether tumour distribution differs depending on the tasks of the Aachen Aphasia Test. The VLSM analysis revealed that single‐word production ( e.g. object naming) was associated with the inferior parietal lobe and that compound and sentence production were additionally associated with posterior temporal gyri. Word repetition was affected in people with tumours in inferior parietal areas, whereas sentence repetition was the only task to be associated with frontal regions. Subcortically, word and sentence production were found to be affected in people with tumours reaching the arcuate fasciculus, and compound production was primarily associated with tumours affecting the inferior longitudinal and inferior fronto‐occipital fasciculus. Our work shows that tasks with linguistic stimuli other than single‐word naming ( e.g. compound and sentence production) relate to additional cortical and subcortical brain areas. At a clinical level, we show that tasks that target the same processes ( e.g. repetition) can have different neural correlates depending on the linguistic stimuli used. Also, we highlight the importance of left temporoparietal areas.
- Open Access
- 5 January 2023
- Published by Springer Nature in Research Square
Improved reliability of intraoperative language testing through pre-operative baseline linguistic scores and baseline object naming
Visual object naming (vON) is the most commonly applied linguistic test during awake surgeries with electrical stimulation mapping. Little is known about the predictive value of general preoperative linguistic and cognitive function for the intraoperative object naming ability of the patient. We aimed at analyzing these correlations, in order to potentially define cut-off values for when intraoperative vON tasks may no longer be gainful. Also, we aimed to assess the benefits of patient-specific tailoring of object-images. 46 patients with left-sided perisylvian tumors, scheduled for awake surgeries, underwent a preoperative workup including a comprehensive test battery for general linguistic function, a cognitive function test, and an object naming task, employing a set of objects that was validated prior in an inhouse study. For intraoperative use, the initial set of 80 objects was tailored down to a slack of objects, each patient could reproducibly name. Correlations between the respective tests were drawn using multivariate analyses. On average, patients were only able to correctly name 81% of the original validated baseline set of objects (range from 16%-88%). Aachen Aphasia Test (AAT) scores and DemTect test scores (DS) correlated tightly with the vON. Patients with initial AAT scores of < 80%, DS of < 50%, and baseline vON scores of < 50% were no longer able to reliably comply with the intraoperative task. Patient specific tailored sets of objects improve the reliability of intraoperative object naming tasks. An elaborate preoperative language evaluation will give an estimate of the expected object naming ability of the patient and will help put into perspective intraoperative performances. There may be cut-off values in a-priori language function that may disqualify for awake surgeries.
- 5 January 2023
- Published by Springer Nature in Research Square
Open AccessImproved reliability of intraoperative language testing through pre-operative baseline linguistic scores and baseline object naming
Visual object naming (vON) is the most commonly applied linguistic test during awake surgeries with electrical stimulation mapping. Little is known about the predictive value of general preoperative linguistic and cognitive function for the intraoperative object naming ability of the patient. We aimed at analyzing these correlations, in order to potentially define cut-off values for when intraoperative vON tasks may no longer be gainful. Also, we aimed to assess the benefits of patient-specific tailoring of object-images. 46 patients with left-sided perisylvian tumors, scheduled for awake surgeries, underwent a preoperative workup including a comprehensive test battery for general linguistic function, a cognitive function test, and an object naming task, employing a set of objects that was validated prior in an inhouse study. For intraoperative use, the initial set of 80 objects was tailored down to a slack of objects, each patient could reproducibly name. Correlations between the respective tests were drawn using multivariate analyses. On average, patients were only able to correctly name 81% of the original validated baseline set of objects (range from 16%-88%). Aachen Aphasia Test (AAT) scores and DemTect test scores (DS) correlated tightly with the vON. Patients with initial AAT scores of < 80%, DS of < 50%, and baseline vON scores of < 50% were no longer able to reliably comply with the intraoperative task. Patient specific tailored sets of objects improve the reliability of intraoperative object naming tasks. An elaborate preoperative language evaluation will give an estimate of the expected object naming ability of the patient and will help put into perspective intraoperative performances. There may be cut-off values in a-priori language function that may disqualify for awake surgeries.
- Open Access
- 10 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (12) , 3330
Correlation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies
The utilization of fluorescein-guided biopsies has recently been discussed to improve and expedite operative techniques in the detection of tumor-positive tissue, as well as to avoid making sampling errors. In this study, we aimed to report our experience with fluorescein-guided biopsies and elucidate distribution patterns in different histopathological diagnoses in order to develop strategies to increase the efficiency and accuracy of this technique. We report on 45 fluorescence-guided stereotactic biopsies in 44 patients (15 female, 29 male) at our institution from March 2016 to March 2021, including 25 frame-based stereotactic biopsies and 20 frameless image-guided biopsies using VarioGuide®. A total number of 347 biopsy samples with a median of 8 samples (range: 4–18) per patient were evaluated for intraoperative fluorescein uptake and correlated to definitive histopathology. The median age at surgery was 63 years (range: 18–87). Of the acquired specimens, 63% were fluorescein positive. Final histopathology included glioblastoma (n = 16), B-cell non-Hodgkin lymphoma (n = 10), astrocytoma, IDH-mutant WHO grade III (n = 6), astrocytoma, IDH-mutant WHO grade II (n = 1), oligodendroglioma, IDH-mutant and 1p/19q-codeleted WHO grade II (n = 2), reactive CNS tissue/inflammation (n = 4), post-transplantation lymphoproliferative disorder (PTLD; n = 2), ependymoma (n = 1), infection (toxoplasmosis; n = 1), multiple sclerosis (n = 1), and metastasis (n = 1). The sensitivity for high-grade gliomas was 85%, and the specificity was 70%. For contrast-enhancing lesions, the specificity of fluorescein was 84%. The number needed to sample for contrast-enhancing lesions was three, and the overall number needed to sample for final histopathological diagnosis was five. Interestingly, in the astrocytoma, IDH-mutant WHO grade III group, 22/46 (48%) demonstrated fluorescein uptake despite no evidence for gadolinium uptake, and 73% of these were tumor-positive. In our patient series, fluorescein-guided stereotactic biopsy increases the likelihood of definitive neuropathological diagnosis, and the number needed to sample can be reduced by 50% in contrast-enhancing lesions.
- 10 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (12) , 3330
Open AccessCorrelation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies
The utilization of fluorescein-guided biopsies has recently been discussed to improve and expedite operative techniques in the detection of tumor-positive tissue, as well as to avoid making sampling errors. In this study, we aimed to report our experience with fluorescein-guided biopsies and elucidate distribution patterns in different histopathological diagnoses in order to develop strategies to increase the efficiency and accuracy of this technique. We report on 45 fluorescence-guided stereotactic biopsies in 44 patients (15 female, 29 male) at our institution from March 2016 to March 2021, including 25 frame-based stereotactic biopsies and 20 frameless image-guided biopsies using VarioGuide®. A total number of 347 biopsy samples with a median of 8 samples (range: 4–18) per patient were evaluated for intraoperative fluorescein uptake and correlated to definitive histopathology. The median age at surgery was 63 years (range: 18–87). Of the acquired specimens, 63% were fluorescein positive. Final histopathology included glioblastoma (n = 16), B-cell non-Hodgkin lymphoma (n = 10), astrocytoma, IDH-mutant WHO grade III (n = 6), astrocytoma, IDH-mutant WHO grade II (n = 1), oligodendroglioma, IDH-mutant and 1p/19q-codeleted WHO grade II (n = 2), reactive CNS tissue/inflammation (n = 4), post-transplantation lymphoproliferative disorder (PTLD; n = 2), ependymoma (n = 1), infection (toxoplasmosis; n = 1), multiple sclerosis (n = 1), and metastasis (n = 1). The sensitivity for high-grade gliomas was 85%, and the specificity was 70%. For contrast-enhancing lesions, the specificity of fluorescein was 84%. The number needed to sample for contrast-enhancing lesions was three, and the overall number needed to sample for final histopathological diagnosis was five. Interestingly, in the astrocytoma, IDH-mutant WHO grade III group, 22/46 (48%) demonstrated fluorescein uptake despite no evidence for gadolinium uptake, and 73% of these were tumor-positive. In our patient series, fluorescein-guided stereotactic biopsy increases the likelihood of definitive neuropathological diagnosis, and the number needed to sample can be reduced by 50% in contrast-enhancing lesions.
- Open Access
- 16 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (10) , 1490
Transcranial versus Direct Cortical Stimulation for Motor-Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (The TRANSEKT-Trial): Study Protocol for a Randomized Controlled Trial
Background: Monitoring of motor function during surgery for supratentorial tumors under general anesthesia applies either transcranial electrical stimulation (TES) or direct cortical stimulation (DCS) to elicit motor-evoked potentials. To date, there is no guideline that favor one method over the other. Therefore, we designed this randomized study to compare between both methods regarding the prediction of postoperative motor deficits and extent of tumor resection. Methods: This is a multicenter (six centers in Germany and one in Switzerland), double blind, parallel group, exploratory, randomized controlled clinical trial. Patients without or with mild paresis, who are scheduled for surgical resection of motor-eloquent brain tumors under general anesthesia will be randomized to surgical resection under TES or surgical resection under DCS. The primary endpoint is sensitivity and specificity in prognosis of motor function 7 days after surgery. The main secondary endpoint is the extent of tumor resection. The study is planned to include 120 patients within 2 years. Discussion: The present exploratory study should compare TES and DCS regarding sensitivity and specificity in predicting postoperative motor deficit and extent of tumor resection to calculate the required number of patients in a confirmatory trial to test the superiority of one method over the other.
- 16 October 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (10) , 1490
Open AccessTranscranial versus Direct Cortical Stimulation for Motor-Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (The TRANSEKT-Trial): Study Protocol for a Randomized Controlled Trial
Background: Monitoring of motor function during surgery for supratentorial tumors under general anesthesia applies either transcranial electrical stimulation (TES) or direct cortical stimulation (DCS) to elicit motor-evoked potentials. To date, there is no guideline that favor one method over the other. Therefore, we designed this randomized study to compare between both methods regarding the prediction of postoperative motor deficits and extent of tumor resection. Methods: This is a multicenter (six centers in Germany and one in Switzerland), double blind, parallel group, exploratory, randomized controlled clinical trial. Patients without or with mild paresis, who are scheduled for surgical resection of motor-eloquent brain tumors under general anesthesia will be randomized to surgical resection under TES or surgical resection under DCS. The primary endpoint is sensitivity and specificity in prognosis of motor function 7 days after surgery. The main secondary endpoint is the extent of tumor resection. The study is planned to include 120 patients within 2 years. Discussion: The present exploratory study should compare TES and DCS regarding sensitivity and specificity in predicting postoperative motor deficit and extent of tumor resection to calculate the required number of patients in a confirmatory trial to test the superiority of one method over the other.